Lawsuit Overview
San Diego, Nov. 14, 2011 (Shareholders Foundation) -- At least three investors in NASDAQ:ANDS shares filed lawsuits against directors of Anadys Pharmaceuticals in effort to block the takeover of Anadys Pharmaceuticalsy Roche for $3.70 per shares. According to one complaint the plaintiff alleges that defendants breached their fiduciary duties owed to ANDS stockholders arising out of t...
You must register (for free) or login to view the entire case.